Project Grant R01DC021954
Award Date
4/15/25
Completion Date
3/31/30
Dollars Obligated
$581K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68178, USA
Similar Awards
This $290,920 federal Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) aims to develop a novel treatment for noise-induced hearing loss (NIHL). The grant recipient, Dermaxon LLC, a biotech company in Missoula, Montana, will pursue research to identify a selective CYP26 inhibitor that can increase retinoic acid levels in the inner ear and promote the...
The National Institute on Deafness and Other Communication Disorders (NIDCD), through the Research Related to Deafness and Communication Disorders (CFDA 93.173) program, awarded Jacaranda Biosciences, Inc. a $304,762 Project Grant to develop and optimize novel compounds that can activate the eIF2B pathway to prevent ototoxicity and hearing loss caused by cisplatin chemotherapy. The key objectives are to: 1) Optimize the efficacy and physicochemical properties of Jacaranda's proprietary eIF2B...
This $676,533 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research to elucidate the genetic underpinnings of adult-onset hearing loss. The principal investigator at the University of Pennsylvania will leverage genome sequencing and mouse models to identify genomic targets of the ZFP719 gene and determine how its misregulation impacts...
This $623,777 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Program (CFDA 93.173), supports research focused on understanding the role of the immune system and inflammation in hearing loss. The primary awardee, The Washington University, will investigate how viral infections like cytomegalovirus (CMV) impact the development of the blood-labyrinth barrier in the inner ear,...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (CFDA 93.173 - Research Related to Deafness and Communication Disorders) provides $767,494 to the University of Miami to develop human inner ear organoid platforms for research into hearing loss and vestibular disorders. The key objectives are to: 1) Establish and optimize human induced pluripotent stem cell-derived 3D inner ear organoid systems from patients with genetic hearing loss,...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $599,219 Project Grant (CFDA 93.173 - Research Related to Deafness and Communication Disorders) to the Massachusetts Eye and Ear Infirmary in Boston, MA. The grant will fund research to investigate the molecular mechanisms underlying the functional diversity of type I spiral ganglion neurons (SGNs) in the cochlea, which play a crucial role in encoding sound intensity. The research aims to characterize the...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $659,164 in funding to the University of Rochester to identify pharmacological modulators, endogenous ligands, and binding partners for the orphan G-protein coupled receptor GPR156. The research aims to elucidate the role of GPR156 in auditory and balance disorders, with the ultimate goal...
This $498,000 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research to develop an ex-vivo porcine round window membrane (RWM) model and evaluate nanovesicles for enhanced, non-surgical delivery of therapeutics into the inner ear. The primary objectives are to: 1) validate the porcine RWM model for drug permeability, 2) identify...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded Creighton University a $381,035 Project Grant under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant, with a project period from May 6, 2024 to April 30, 2027, will support research to understand the role of stress hormones in Meniere's disease, a disorder affecting the inner ear that can cause vertigo, hearing loss, tinnitus, and a feeling of pressure or fullness...
The Project Grant award R43DC021615 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173). The $275,371 award to Auricle Health Inc. in Oakland, CA will fund the development of an extracochlear device to restore high-frequency hearing for patients with sensorineural hearing loss, a condition affecting over 460 million people worldwide. In Phase I, the...